Mr Doughty and Mr Kraus will assume responsibilities previously performed by John Borrell, who has left the company to pursue other opportunities. Additionally, the company announced that Nabil Dib, has been appointed to serve as medical advisor to Cardiovascular Systems (CSI).
Mr Doughty came to CSI in November 2006 as director of marketing and was named vice president of marketing in August 2007. Prior to joining CSI, he served as director of marketing at Ekos, a manufacturer of an endovascular treatment system for vascular clots.
Mr Kraus has been with CSI since September 2006, most recently as a senior sales director. Previously, he held sales management positions with Boston Scientific, Guidant and CR Bard.
David Martin, president and CEO of CSI, said: “These promotions recognize the outstanding work and abilities of Brian and Scott. Together, they have nearly 30 years of medical device industry experience. They have the skills, experience and drive to implement marketing and sales strategies to accelerate adoption of our Diamondback 360 degrees Orbital Atherectomy System for peripheral arterial disease, as well as lead a growing national sales organization of over 100 professionals.”